Ameriprise’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$72.5M Buy
872,796
+481,408
+123% +$40M 0.02% 685
2025
Q1
$31.7M Sell
391,388
-359,702
-48% -$29.2M 0.01% 1052
2024
Q4
$67.6M Sell
751,090
-96,730
-11% -$8.71M 0.02% 698
2024
Q3
$83.8M Sell
847,820
-23,976
-3% -$2.37M 0.02% 637
2024
Q2
$80.8M Buy
871,796
+307,197
+54% +$28.5M 0.02% 601
2024
Q1
$53.6M Buy
564,599
+226,541
+67% +$21.5M 0.01% 774
2023
Q4
$29.9M Sell
338,058
-330,006
-49% -$29.2M 0.01% 1033
2023
Q3
$48.7M Sell
668,064
-37,060
-5% -$2.7M 0.02% 749
2023
Q2
$58.7M Buy
705,124
+178,026
+34% +$14.8M 0.02% 694
2023
Q1
$40.2M Sell
527,098
-130,863
-20% -$9.97M 0.01% 859
2022
Q4
$54.6M Buy
657,961
+199,868
+44% +$16.6M 0.02% 690
2022
Q3
$36.3M Buy
458,093
+235,318
+106% +$18.7M 0.01% 828
2022
Q2
$15.9M Buy
222,775
+77,859
+54% +$5.56M 0.01% 1380
2022
Q1
$13M Buy
144,916
+45,272
+45% +$4.05M ﹤0.01% 1685
2021
Q4
$11.3M Buy
99,644
+4,276
+4% +$484K ﹤0.01% 1891
2021
Q3
$12.3M Buy
95,368
+4,160
+5% +$537K ﹤0.01% 1677
2021
Q2
$11.9M Sell
91,208
-14,662
-14% -$1.92M ﹤0.01% 1791
2021
Q1
$14.4M Buy
105,870
+2,877
+3% +$391K ﹤0.01% 1576
2020
Q4
$14.5M Sell
102,993
-46,389
-31% -$6.55M 0.01% 1456
2020
Q3
$16.6M Sell
149,382
-4,978
-3% -$554K 0.01% 1193
2020
Q2
$16.3M Buy
154,360
+80,767
+110% +$8.55M 0.01% 1185
2020
Q1
$5.7M Sell
73,593
-13,955
-16% -$1.08M ﹤0.01% 1823
2019
Q4
$8.38M Sell
87,548
-25,582
-23% -$2.45M ﹤0.01% 1889
2019
Q3
$8.56M Sell
113,130
-19,606
-15% -$1.48M ﹤0.01% 1820
2019
Q2
$11.6M Sell
132,736
-11,880
-8% -$1.04M 0.01% 1605
2019
Q1
$13M Buy
144,616
+19,248
+15% +$1.73M 0.01% 1479
2018
Q4
$9M Sell
125,368
-72,630
-37% -$5.21M ﹤0.01% 1687
2018
Q3
$19M Buy
197,998
+24,286
+14% +$2.33M 0.01% 1345
2018
Q2
$16.5M Buy
173,712
+40,503
+30% +$3.86M 0.01% 1315
2018
Q1
$11.7M Buy
133,209
+15,186
+13% +$1.33M 0.01% 1544
2017
Q4
$10M Buy
118,023
+6,966
+6% +$590K ﹤0.01% 1611
2017
Q3
$9.61M Buy
111,057
+921
+0.8% +$79.7K ﹤0.01% 1610
2017
Q2
$8.5M Buy
110,136
+26,752
+32% +$2.06M ﹤0.01% 1691
2017
Q1
$5.78M Buy
83,384
+23,233
+39% +$1.61M ﹤0.01% 1918
2016
Q4
$3.55M Sell
60,151
-295,155
-83% -$17.4M ﹤0.01% 2311
2016
Q3
$23.6M Buy
355,306
+74,865
+27% +$4.96M 0.01% 837
2016
Q2
$15.2M Sell
280,441
-7,602
-3% -$411K 0.01% 1084
2016
Q1
$14.9M Buy
288,043
+239,550
+494% +$12.4M 0.01% 1123
2015
Q4
$3.4M Sell
48,493
-7,224
-13% -$507K ﹤0.01% 2293
2015
Q3
$3.45M Buy
55,717
+4,921
+10% +$305K ﹤0.01% 2262
2015
Q2
$4.27M Buy
50,796
+36,642
+259% +$3.08M ﹤0.01% 2248
2015
Q1
$1.06M Buy
14,154
+5,511
+64% +$414K ﹤0.01% 2927
2014
Q4
$537K Buy
8,643
+3,561
+70% +$221K ﹤0.01% 3090
2014
Q3
$264K Sell
5,082
-1,521
-23% -$79K ﹤0.01% 3281
2014
Q2
$336K Sell
6,603
-825
-11% -$42K ﹤0.01% 3121
2014
Q1
$353K Sell
7,428
-2,190
-23% -$104K ﹤0.01% 3063
2013
Q4
$417K Buy
9,618
+4,686
+95% +$203K ﹤0.01% 2921
2013
Q3
$212K Buy
4,932
+1,020
+26% +$43.8K ﹤0.01% 3160
2013
Q2
$136K Buy
+3,912
New +$136K ﹤0.01% 3249